Literature DB >> 5791298

L-dopa in parkinson's syndrome.

G C Cotzias, P S Papavasiliou, R Gellene.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5791298     DOI： 10.1056/NEJM196907312810518

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Dr Lewis Kitchener Dahl, the Dahl rats, and the "inconvenient truth" about the genetics of hypertension.

Authors:  Bina Joe
Journal:  Hypertension       Date:  2015-02-02       Impact factor: 10.190

2.  Reply: Levodopa increases functional connectivity in the cerebellum and brainstem in Parkinson's disease.

Authors:  Abraham Z Snyder; Joel S Perlmutter; Carl D Hacker
Journal:  Brain       Date:  2013-02-11       Impact factor: 13.501

3.  Adjuvants to L-dopa for Parkinsonism.

Authors:  J Braham
Journal:  Br Med J       Date:  1970-05-30

4.  L-DOPA in Parkinson's Disease.

Authors:  F H McDowell; J E Lee
Journal:  Calif Med       Date:  1970-10

5.  Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.

Authors:  Jerrold L Vitek; Luke A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 6.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

Review 7.  Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease.

Authors:  Peter Redgrave; Manuel Rodriguez; Yoland Smith; Maria C Rodriguez-Oroz; Stephane Lehericy; Hagai Bergman; Yves Agid; Mahlon R DeLong; Jose A Obeso
Journal:  Nat Rev Neurosci       Date:  2010-10-14       Impact factor: 34.870

Review 8.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

Review 9.  Therapeutic approaches in Parkinson's disease and related disorders.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

10.  Dopamine signaling is essential for precise rates of locomotion by C. elegans.

Authors:  Daniel T Omura; Damon A Clark; Aravinthan D T Samuel; H Robert Horvitz
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.